Oct 25, 2019
We delve into the whirlwind story of Elizabeth Holmes and her biotech company Theranos. At its height, valued at 9 billion dollars. At its heart, a product that didn't work.
In this compelling book, Wall Street Journal writer John Carreyrou sets out his dogged efforts to penetrate the wall of fear and intimidation that hid the truth. Gripping stuff, but did it make for a good book club read? What did Kate's book club think?
Listen in to find out.